Translatomics for liver cancer, prostate cancer, and acute myeloid leukaemia
Recent Publications Harnessing the Power of Translatomics Every week we provide a digest of a small number of recent interesting papers in the field of translatomics. In this week’s Sunday papers, Contreras et al. find using polysome-seq that sorafenib causes global suppression of translation and also uses selective translation to treat hepatocellular carcinoma. Cordova et […]